• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0); INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0); INTRODUCER, CATHETER Back to Search Results
Catalog Number DSF2433
Device Problem Off-Label Use (1494)
Patient Problem Vascular Dissection (3160)
Event Date 08/02/2019
Event Type  Injury  
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.The gore® dryseal flex introducer sheath instruction for use (ifu) states ¿adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vessel damage, or serious injury to the patient, including death, may result.¿ per ifu, if vessel size is smaller than the nominal body outer diameter, major bleeding, vessel damage, or serious injury to the patient, including death, may result.Additionally, per ifu, adverse events that may occur and/or require intervention include, but are not limited to vascular trauma (i.E., dissection, rupture, perforation, tear, etc.).
 
Event Description
On (b)(6) 2019, the patient underwent endovascular repair of a thoracic aortic aneurysm with a conformable gore® tag® thoracic endoprosthesis using a gore® dryseal flex introducer sheath.The sheath was inserted into the patient from the right femoral artery.After the deployment of the endoprosthesis and removal of the sheath, an injury was observed at the right femoral artery.The cut down site and where and the injury to the femoral artery were located and sutured.After suturing the femoral artery, the artery reportedly narrowed and the physician then ballooned the artery open back to the original size.The patient reportedly tolerated the procedure.The reported vessel diameters for the right femoral artery were approximately 7.0 mm ¿ 8.0 mm.The physician stated, ¿there was a resistance during the advancement of the sheath in the right femoral artery.The diameter of the access vessel was small.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0)
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
sara collum
1500 n. 4th street
9285263030
MDR Report Key8913541
MDR Text Key155787575
Report Number3007284313-2019-00257
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00733132630950
UDI-Public00733132630950
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/23/2022
Device Catalogue NumberDSF2433
Device Lot Number20300480
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/24/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age85 YR
-
-